Abstract
Background We recently reported that a green-Mediterranean (green-MED), high-polyphenol diet is potentially neuroprotective for age-related brain atrophy. Here, we explored the interplay between dietary intervention, proteomics profile, and accelerated brain age.
Methods In the 18-month DIRECT PLUS trial, 294 participants (adherence rate=89%) were randomized to one of three arms: 1) Healthy dietary guidelines (HDG); 2) MED diet; or 3) green-MED diet. Both MED diets included 28g/day of walnuts. Additionally, the low red/processed meat green-MED group received daily supplements of polyphenol-rich green-tea and green Mankai aquatic plant. In this secondary analysis, we measured 87 serum proteins (Olink-CVDII) and conducted Magnetic Resonance Imaging (MRI) to obtain brain 3D-T1-weighted for brain age calculation based on brain convolutional neural network to identify protein markers reflecting the brain age gap (BAG: residual deviation of MRI-assessed brain age from chronological age).
Results We analyzed eligible brain MRIs (216 at baseline and 18-month) for BAG calculation. At baseline (age=51.3yrs, 90% men), lower weight, waist circumference, diastolic blood pressure, and HbA1c parameters were associated with younger brain age than expected (p<0.05 for all). At baseline, higher levels of two specific proteins: Galectin-9 (Gal-9) and Decorin (DCN), were associated with larger BAG (accelerated brain aging; FDR<0.05). A proteomics principal component analysis (PCA) revealed a significant difference between the 18-month time points among participants who completed the trial with accelerated brain aging (p=0.02). Between baseline and 18 months, Gal-9 significantly decreased (p<0.05) among individuals who completed the intervention with attenuated brain age, and DCN significantly increased (p<0.05) among those who completed the trial with accelerated brain age. A significant interaction was observed between the green-MED diet and proteomics PCA change compared to the HDG (β=-1.7; p-interaction=0.05). Participants in the green-MED diet significantly decreased Gal-9 compared to the HDG diet (p=0.015) and from baseline (p=0.003). DCN levels, however, marginally increased in the HDG diet from baseline (p=0.053).
Conclusion Higher serum levels of Gal-9 and DCN may indicate an acceleration of brain aging and might be reduced by the green-MED/high-polyphenol diet rich in Mankai and green-tea and low in red/processed meat.
Trial registration number NCT03020186.
Competing Interest Statement
MB received honoraria for lectures and consultancy from Amgen, Astra Zeneca, Bayer, Boehringer-Ingelheim, Lilly, Novartis, Novo Nordisk, and Sanofi. All other authors report no conflicts of interest.
Clinical Trial
NCT03020186
Funding Statement
This study was supported by the German Research Foundation (DFG) project number 209933838 (SFB 1052; B11) (to I Shai); the Israel Ministry of Health grant 87472511 (to I Shai); the Israel Ministry of Science and Technology grant 3-13604 (to I Shai); and the California Walnut Commission (to I Shai). DP is a recipient of the Kreitman Doctoral Fellowship at the Ben-Gurion University of the Negev. AYM was supported by the Council for Higher Education- Zuckerman support program for outstanding postdoctoral female researchers. None of the funding providers were involved in any stages of the design, conducting, or analysis of the study, nor did they have access to the study results prior to publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Soroka Medical Center gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
All data described in the article, code book, and analytic code will be made available upon request, pending the approval of the principal investigator (irish{at}bgu.ac.il).
List of abbreviations
- AD
- Alzheimer disease
- ALKP
- alkaline phosphatase
- ALT
- alanine transaminase
- BAG
- Brain age gap
- BMI
- body mass index
- BP
- Blood pressure
- CNN
- convolutional neural network
- CRP
- C-reactive protein
- CSF
- cerebral-spinal fluid
- CVD
- cardiovascular disease
- DCN
- Decorin
- ECM
- extracellular matrix
- FDR
- false discovery rate
- Gal-9
- Galectin 9
- green-MED diet
- Mediterranean diet higher in polyphenols and lower in red/processed meat
- HbA1c
- Hemoglobin A1c
- HDG
- Healthy dietary guidelines
- HDLc
- High-density lipoprotein cholesterol
- HOC
- Hippocampal Occupancy Score
- IQR
- Interquartile Range
- LDLc
- Low-density lipoprotein cholesterol
- LVV
- lateral ventricle volume
- MCI
- Mild cognitive impairment
- MED
- Mediterranean diet
- MRI
- Magnetic-Resonance-Imaging
- NPX
- normalized protein expression
- PA
- Physical activity
- PCA
- principal component analysis
- PEA
- proximity extension assay
- RMSE
- root mean square error
- TG
- Triglyceride
- WC
- Waist circumference
